Galenea's Grant - II Round

Galenea raised a round of funding on October 19, 2009. Investors include National Institutes of Health.

Galenea is a biopharmaceutical company discovering and developing drugs to treat schizophrenia and other central nervous system diseases. The company has developed technology, the MANTRA (Multiwell, A…

Articles about Galenea's Grant - II Round: